A phase II study of RC48-ADC in HER2-negative patients with locally advanced or metastatic urothelial carcinoma.

Xu, HY; Sheng, XN; Yan, XQ; Chi, ZH; Cui, CL; Si, L; Tang, BX; Mao, LL; Lian, B; Wang, X; Li, SM; Zhou, L; Bai, X; Guo, J

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索